Skip to main content
Erschienen in: Rheumatology International 8/2013

01.08.2013 | Original Article

Quantitative sensory testing in fibromyalgia and hemisensory syndrome: comparison with controls

verfasst von: Luciana Alvarenga da Silva, Helena Hideko Seguchi Kazyiama, Manoel Jacobsen Teixeira, Silvia Regina Dowgan Tesseroli de Siqueira

Erschienen in: Rheumatology International | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Fibromyalgia syndrome (FS) is a chronic painful condition with sensory, motor and affective dysfunctions. Few studies had investigated the trigeminal area, and little is known about its association with hemisensory syndrome, which is characterized by chronic pain restricted to hemibody. Our objective was to investigate sensorial abnormalities with quantitative sensory testing of patients with FS and patients with hemisensory syndrome, compared to controls. Thirteen patients diagnosed with FS according to the American College of Rheumatology, and 12 patients with hemisensory syndrome were evaluated and compared to 25 age–gender-matched controls. They were investigated with a quantitative sensory testing protocol including gustative, olfactory, cold, warm, touch, vibration, electric, deep and superficial pain thresholds and the corneal reflex evaluation. The patients had higher gustative thresholds for salty and bitter. In general, patients with FS had somatosensory thresholds higher than the controls; however, patients with hemisensory syndrome had only superficial pain thresholds increased, in both body sides and not only in the area affected by pain. Patients with hemisensory syndrome can be a subgroup of FS, different from nondermatomal somatosensory deficits which are characterized by chronic pain with hypoesthesia in hemibody. The bilateral hypoalgesia supports that pain pathways play a key role in this condition, with no compromise of other sensorial modalities.
Literatur
1.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
2.
Zurück zum Zitat Zoppi M, Maresca M (2008) Symptoms accompanying fibromyalgia. Rheumatism 60:217–220 Zoppi M, Maresca M (2008) Symptoms accompanying fibromyalgia. Rheumatism 60:217–220
3.
Zurück zum Zitat Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227PubMedCrossRef Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227PubMedCrossRef
4.
Zurück zum Zitat Bartels EM, Dreyer L, Jacobsen S et al (2009) Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskr Laeger 171:3588–3592PubMed Bartels EM, Dreyer L, Jacobsen S et al (2009) Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskr Laeger 171:3588–3592PubMed
5.
Zurück zum Zitat Staud R, Koo E, Robinson ME, Price DD (2007) Spatial summation of mechanically evoked muscle pain and painful after sensations in normal subjects and fibromyalgia patients. Pain 130:177–187PubMedCrossRef Staud R, Koo E, Robinson ME, Price DD (2007) Spatial summation of mechanically evoked muscle pain and painful after sensations in normal subjects and fibromyalgia patients. Pain 130:177–187PubMedCrossRef
6.
Zurück zum Zitat Vierck Junior CJ (2006) Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 124:242–263CrossRef Vierck Junior CJ (2006) Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 124:242–263CrossRef
7.
Zurück zum Zitat Hsu MC, Harris RE, Sundgren PC et al (2009) No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain 143:262–267PubMedCrossRef Hsu MC, Harris RE, Sundgren PC et al (2009) No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain 143:262–267PubMedCrossRef
8.
Zurück zum Zitat Smith WS, Tooley EM, Montague EQ et al (2008) Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 140:420–428PubMedCrossRef Smith WS, Tooley EM, Montague EQ et al (2008) Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 140:420–428PubMedCrossRef
9.
Zurück zum Zitat Desmeules JA, Cedraschi C, Rapiti E et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48:1420–1429PubMedCrossRef Desmeules JA, Cedraschi C, Rapiti E et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48:1420–1429PubMedCrossRef
10.
Zurück zum Zitat Klauenberg S, Maier C, Assion HJ et al (2008) Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 140:332–343PubMedCrossRef Klauenberg S, Maier C, Assion HJ et al (2008) Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 140:332–343PubMedCrossRef
11.
Zurück zum Zitat Kosek E, Ekholm J, Hansson P (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68:375–383PubMedCrossRef Kosek E, Ekholm J, Hansson P (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68:375–383PubMedCrossRef
12.
Zurück zum Zitat Watson NF, Buchwald D, Goldberg J et al (2009) Neurological signs and symptoms in fibromyalgia. Arthritis Rheum 60:2839–2844PubMedCrossRef Watson NF, Buchwald D, Goldberg J et al (2009) Neurological signs and symptoms in fibromyalgia. Arthritis Rheum 60:2839–2844PubMedCrossRef
13.
Zurück zum Zitat Kazyiama HHS, Teixeira MJ, Lin TY (1999) Fibromyalgia and hemisensitive syndromes. IASP 9th world congress on pain. Vienna, p 550 (abstract) Kazyiama HHS, Teixeira MJ, Lin TY (1999) Fibromyalgia and hemisensitive syndromes. IASP 9th world congress on pain. Vienna, p 550 (abstract)
14.
Zurück zum Zitat Egloff N, Sabbioni ME, Salathé C et al (2009) Nondermatomal somatosensory deficits in patients with chronic pain disorder: clinical findings and hypometabolic pattern in FDG-PET. Pain 145:252–258PubMedCrossRef Egloff N, Sabbioni ME, Salathé C et al (2009) Nondermatomal somatosensory deficits in patients with chronic pain disorder: clinical findings and hypometabolic pattern in FDG-PET. Pain 145:252–258PubMedCrossRef
15.
Zurück zum Zitat Siviero M, Teixeira MJ, Siqueira JTT, Siqueira SRDT (2010) Somesthetic, gustatory, olfactory function and salivary flow in patients with trigeminal neuropathic pain. Oral Dis 16:482–487PubMedCrossRef Siviero M, Teixeira MJ, Siqueira JTT, Siqueira SRDT (2010) Somesthetic, gustatory, olfactory function and salivary flow in patients with trigeminal neuropathic pain. Oral Dis 16:482–487PubMedCrossRef
16.
Zurück zum Zitat Chong YY, Ng BY (2009) Clinical aspects and management of fibromyalgia syndrome. Ann Acad Med Singapore 38:967–973PubMed Chong YY, Ng BY (2009) Clinical aspects and management of fibromyalgia syndrome. Ann Acad Med Singapore 38:967–973PubMed
Metadaten
Titel
Quantitative sensory testing in fibromyalgia and hemisensory syndrome: comparison with controls
verfasst von
Luciana Alvarenga da Silva
Helena Hideko Seguchi Kazyiama
Manoel Jacobsen Teixeira
Silvia Regina Dowgan Tesseroli de Siqueira
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 8/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2675-6

Weitere Artikel der Ausgabe 8/2013

Rheumatology International 8/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.